Louis J Nisbet, chairman of BioCity Nottingham, has joined the board of Sygnature Discovery Ltd as a non-executive director. Sygnature is located at the BioCity incubator facility in Nottingham, UK and provides drug discovery services for pharmaceutical and biotech companies and academic institutions in Europe and the US. Dr Nisbet is a serial entrepreneur and currently a venture partner with Kurma Life Sciences Partners in Paris, France.
Sygnature Discovery announced the appointment on 30 September 2013.
Copyright 2013 Evernow Publishing Ltd